Amicus Therapeutics
FOLDNASDAQAcquiredRare disease biologics and small-molecule chaperone platform
Drafted with AI assistance from public sources and not individually reviewed by an editor; last updated 2026-04-09. Published by ClinicalInvestor. Educational analysis only. Read the editorial policy and disclosures.
text updated 2026-04-09, 222 days ago · archived: kept for reference, not maintained · where each field comes from
Pipeline at the time of the last update
| Drug | Indication | Phase | Expected data | |
|---|---|---|---|---|
| Galafold | Fabry disease | Approved | Not disclosed | ▼ |
| Pombiliti + Opfolda | late-onset Pompe disease | Approved | Not disclosed | ▼ |